"10.1371_journal.pone.0043336","none","2012-09-04T00:00:00Z","Nasheeta Peer; Krisela Steyn; Carl Lombard; Estelle V Lambert; Bavanisha Vythilingum; Naomi S Levitt","Chronic Diseases of Lifestyle Unit, Medical Research Council, Durban, South Africa; Chronic Disease Initiative in Africa, Department of Medicine, University of Cape Town, Cape Town, South Africa; Biostatistics Unit, Medical Research Council, Cape Town, South Africa; University of Cape Town/Medical Research Council Research Unit for Exercise Science and Sports Medicine, Cape Town, South Africa; Department of Psychiatry, University of Cape Town, Cape Town, South Africa; Division of Endocrinology and Diabetes, Department of Medicine, University of Cape Town, Cape Town, South Africa","Conceived and designed the experiments: NP KS CL NSL. Analyzed the data: NP CL EVL. Contributed reagents/materials/analysis tools: BV. Wrote the paper: NP KS CL EVL BV NSL.","NL has received honoraria from Novartis for serving on the steering committee for the Navigator Trial and travel support from Novo Nordisk, Eli Lilly Laboratories and Sanofi Aventis. All other authors report no potential conflicts of interest, including specific financial interests, relevant to the subject of this manuscript. This study was partially funded by a commercial source (Servier Laboratories [South Africa]). This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.","2012","09","Nasheeta Peer","NP",6,TRUE,4,NA,3,6,TRUE,TRUE,FALSE,0,NA,FALSE
